FET Protocol Guide: Medicated vs Natural Frozen Embryo Transfer
Published: May 2026 · 12 min read
Medicated
Predictable timing
Natural
Lower OB risks
7–14 mm
Lining target
10 ng/mL
P4 transfer target
Choosing your FET protocol matters more than many patients realise. Medicated and natural cycles produce broadly similar pregnancy rates, but recent evidence suggests differences in live birth rates and obstetric outcomes. ESHRE 2023 guidance leans toward natural cycles where feasible. This guide walks through what each protocol involves, who each suits, and the trade-offs that matter when deciding.
The headline: for patients who ovulate regularly, natural or modified natural FET is increasingly the preferred protocol on outcome grounds. For patients without regular ovulation, or with strong scheduling constraints, medicated FET remains the right practical choice. Talk to your clinic — many do not yet default to natural cycles.
Which FET protocol is better for me?
It depends on your cycle, schedule, and clinic preferences. Medicated FET is preferred for irregular ovulation (PCOS, perimenopausal), schedule constraints (cross-border, work), donor egg or surrogate cycles, and prior failed natural cycles. Natural and modified natural FET are preferred for regular ovulators, patients who can accommodate monitoring, and patients prioritising lower obstetric risk based on recent evidence (ESHRE 2023 guidance favours natural where feasible).
Does FET protocol affect pregnancy success rates?
Pregnancy rates are broadly similar between protocols. Live birth rates appear modestly higher with natural and modified natural FET in recent randomised trials. Obstetric outcomes (preeclampsia, large-for-gestational-age) appear better with natural cycles where the corpus luteum produces hormones throughout early pregnancy. The differences are real but not dramatic — many patients still appropriately do medicated FET.
In This Article
The Three FET Protocol Types
| Protocol | Hormones from | Best for |
|---|---|---|
| Medicated (HRT, programmed) | External meds only | Irregular cycles, scheduling control, donor / surrogate |
| Natural | Patient's own ovulation | Regular cycles, lower OB risk priority |
| Modified natural | Mostly natural + trigger + minimal P4 | Regular cycles, slight schedule control needed |
Medicated FET in Detail
Typical medicated FET timeline
- Day 1–2 (cycle start): Start oral or transdermal estrogen
- Days 8–12: First scan to check lining and estradiol
- Days 12–14: Lining target 7–14 mm trilaminar; estradiol target 150–500 pg/mL
- Days 14–18: Start progesterone (vaginal, intramuscular, or both)
- Day 5 of progesterone: Embryo transfer (for day-5 blastocyst)
- Continue both estrogen and progesterone through 8–12 weeks of pregnancy if successful
Pros
- • Predictable timing — transfer date set in advance
- • Suitable for any cycle pattern
- • Required for donor egg and surrogate cycles (synchronisation)
- • Fewer monitoring visits than natural cycle
Cons
- • Higher medication burden (estrogen + progesterone for weeks)
- • No corpus luteum, so no natural hormone production through early pregnancy
- • Modestly elevated preeclampsia risk in recent evidence
- • Modestly elevated large-for-gestational-age risk
- • Slightly lower live birth rate in some trials
Natural FET in Detail
Typical natural FET timeline
- Cycle day 1: Period starts; cycle begins
- Days 8–10: Begin LH surge testing (urine kits or blood)
- Days 10–14: Ultrasound to track follicle growth
- LH surge detected: Ovulation expected 24–36 hours later
- Ovulation confirmed (scan): Day 0 of luteal phase
- Day 5–7 post-ovulation: Embryo transfer (for day-5 blastocyst)
- Often: Vaginal progesterone supplementation from ovulation through early pregnancy
Pros
- • Minimal or no hormonal medication
- • Corpus luteum produces natural hormones through early pregnancy
- • Recent evidence: lower preeclampsia, lower LGA risk
- • Modestly higher live birth rate in some trials
- • Less "medicalised" experience preferred by some patients
Cons
- • Less predictable timing — depends on your ovulation
- • Requires regular ovulation
- • More monitoring visits (LH testing, scans)
- • Cycle cancellation if ovulation does not occur or is missed
- • Cross-border patients: scheduling around ovulation is harder
Your IVF journey, organised and free
IVFPath is built for IVF patients — track medications, appointments, lab results, and costs all in one place.
Medication Reminders
Never miss a dose — log every injection and tablet
Appointment Calendar
All your scans, retrievals and transfers in one view
Cost Tracker
Track spending so nothing is a surprise
Free · No credit card · Works on any device
Modified Natural FET
Modified natural FET is a middle ground. Patient ovulates naturally, but an ovulation trigger (hCG or agonist) is given when the lead follicle reaches the right size, and progesterone supplementation supports the luteal phase.
- Slightly more schedule control than fully natural — trigger sets ovulation timing
- Mostly natural hormone profile
- Outcomes appear similar to natural FET
- Often the practical default at clinics that prefer natural protocols but need some control
What the Evidence Says
Several large randomised trials and meta-analyses since 2020 have compared FET protocols. Headlines:
- Pregnancy rates: Broadly similar across protocols
- Live birth rates: Modestly higher with natural and modified natural in some recent trials
- Preeclampsia: Lower with natural cycles (corpus luteum produces vasoactive factors that medicated cycles lack)
- Large-for-gestational-age babies: Lower with natural cycles
- Postpartum haemorrhage: Possibly lower with natural cycles
ESHRE 2023 guidance
ESHRE's 2023 guideline on FET cycles leans toward natural or modified natural protocols where feasible, citing the obstetric outcome data. Many clinics have not yet adapted practice — if your clinic defaults to medicated FET, ask explicitly whether natural is an option for your situation.
Choosing for Your Situation
Lean toward medicated FET if
- • Irregular cycles or anovulation (PCOS, perimenopausal)
- • Cross-border patient with limited scheduling flexibility
- • Donor egg or surrogate cycle (synchronisation needed)
- • Prior failed natural FET
- • Strong work or life schedule constraints
- • Patient prefers maximum predictability
Lean toward natural / modified natural FET if
- • Regular ovulatory cycles
- • Patient prefers minimum medication
- • Schedule allows for monitoring visits
- • Prior preeclampsia or hypertension history
- • Patient values recent obstetric outcome evidence
- • Clinic regularly runs natural protocols
Progesterone Support Details
- Vaginal progesterone (Cyclogest, Crinone, Lutigest): Most common; well-tolerated; sometimes irritating
- Intramuscular progesterone in oil (PIO): Daily injection; sometimes preferred for medicated FET; site soreness common
- Combined vaginal + IM: Some clinics use both; debated whether necessary
- Oral progesterone: Less common for transfer support; often used as adjunct
- Subcutaneous progesterone: Newer option in some markets; less site reaction than IM
Choosing your protocol with confidence?
FET protocol selection is one of the higher-leverage decisions in your IVF cycle — with real differences in convenience and outcomes. Nestie's AI assistant can help you walk through your specific situation and the questions to bring to your clinic.
Plan your FET with Nestie →Frequently Asked Questions
References
Information based on ESHRE 2023 guideline on FET cycles, multiple recent randomised trials comparing medicated vs natural protocols (Natural-FET trial and similar), and ASRM practice committee guidance on luteal phase support. Individual protocol selection should involve your reproductive endocrinologist with knowledge of your specific history.